Weighting Must Wait Allan WailooAki TsuchiyaChristopher McCabe Current Opinion 17 September 2012 Pages: 983 - 989
Cost Effectiveness of Herpes Zoster Vaccine in Canada Mehdi NajafzadehCarlo A. MarraDavid M. Patrick Original Research Article 17 September 2012 Pages: 991 - 1004
Willingness to Pay for a QALY Based on Community Member and Patient Preferences for Temporary Health States Associated with Herpes Zoster Tracy A. LieuG. Thomas RayDonna Rusinak Original Research Article 17 September 2012 Pages: 1005 - 1016
Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials Aline GauthierAndrea MancaSusan Anton Original Research Article 17 September 2012 Pages: 1017 - 1029
Healthcare Costs and Obesity Prevention David R. RappangeWerner B. F. BrouwerPieter H. M. Van Baal Original Research Article 17 September 2012 Pages: 1031 - 1044
Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK Jeroen P. JansenRitesh KumarYehuda Carmeli Original Research Article 17 September 2012 Pages: 1045 - 1056